Who
Christian S. Schade
Director
Company insider
Files Form 4 as: Director, Integra LifeSciences Holdings; Director, Omega Therapeutics; Chairman & CEO, Aprea Therapeutics; Executive VP and CFO, Omthera Pharmaceuticals; Exec VP & Chief Financial Ofc, NRG Energy; SVP & CFO, Medarex.
In numbers
- Trades disclosed
- 130
- Buys
- 2
- Sells
- 4
- Bought
- $189K
- Sold
- $2.5M
- Companies
- 6
- Companies where not an officer
- 2
- First trade
- 19 Sep 2001
- Last trade
- 7 May 2026
- Last filed
- 11 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 May 2026filed 11 May 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,700 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | IART Integra LifeSciences Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,700 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —6,939 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —19,592 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —8,696 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —512,848 at $0.00 | filing |
| 10 Jul 2023filed 9 Feb 2024 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —36,713 at $0.00 | filing |
| 10 Jul 2023filed 12 Jul 2023 | Omega Therapeuticsoption or derivative | SEC FORM 4 Code A | —36,713 at $0.00 | filing |
| 12 May 2023filed 16 May 2023 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —4,486 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,600 at $0.00 | filing |
| 28 Jul 2022filed 1 Aug 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —32,400 at $0.00 | filing |
| 3 Jun 2022filed 7 Jun 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code F | $53K65,770 at $0.81 | filing |
| 18 May 2022filed 19 May 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Bought | $24K37,500 at $0.64 | filing |
| 13 May 2022filed 17 May 2022 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —1,265 at $0.00 | filing |
| 13 May 2022filed 17 May 2022 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —3,456 at $0.00 | filing |
| 10 Mar 2022filed 14 Mar 2022 | APRE Aprea Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —427,700 at $0.00 | filing |
| 10 Mar 2022filed 14 Mar 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code A | —100,100 at $0.00 | filing |
| 25 Feb 2022filed 1 Mar 2022 | APRE Aprea TherapeuticsBiotechnology | SEC FORM 4 Code F | $38K21,644 at $1.74 | filing |
| 14 May 2021filed 17 May 2021 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —530 at $0.00 | filing |
News
Reviewing Aprea Therapeutics (NASDAQ:APRE) & Oncobiologics (NASDAQ:OTLK)APRE · themarketsdaily.com · 20 Oct 2026Comparing Precision Optics (NASDAQ:POCI) & Integra LifeSciences (NASDAQ:IART)IART · themarketsdaily.com · 19 Oct 2026Integra LifeSciences (NASDAQ: IART) prices $450 million notes to refinance debtIART · tickerreport.com · 13 Oct 2026Integra LifeSciences Prices $450 Mln Of 9.5% Senior Secured Notes Due 2033IART · rttnews.com · 12 Oct 2026Reviewing Aprea Therapeutics (NASDAQ:APRE) & CRISPR Therapeutics (NASDAQ:CRSP)APRE · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Christian S. Schade; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.